8:00 am
Welcome to Stanford
Gary K. Steinberg MD, PhD
Stanford, CA, USA

8:05 am
Introduction:
Why the need for an "active international working group"
Nadia Khan MD
Stanford, CA, USA

Morning Session
8:15 am to 10:15 am Session Moderator: Mario Zuccarello, MD, Cincinnati , OH, USA
10:35 am to 12:05 pm Session Moderator: David W Newell, MD, Seattle, WA, USA

8:15 am
Burden of Disease in the UK
Martin Brown MD
London, UK

8:45 am
Genetics of Familial Moyamoya Disease
Yohei Mineharu MD, PhD
Kyoto, Japan

9:15 am
Direct and Indirect Revascularization for European Adult Moyamoya Angiopathy
Daniel Haenggi MD
Duesseldorf, Germany

9:45 am
The Stanford experience
Gary K. Steinberg MD, PhD
Stanford, CA, USA

10:15 am to 10:35 am
Break

10:35 am
Management of Childhood Moyamoya Disease, Non-invasive Biomarkers in Moyamoya
Edward R. Smith M.D
Boston, MA, USA

11:05 am
EPC in cerebrovascular disease, focusing on Moyamoya disease
Jae-Kyu Roh, MD
Seoul, Korea

11:35 am
Management of Headache, Hypertension and Systemic Diseases in Moyamoya Angiopathy
Vijeya Ganesan MD
London, UK

12:05 pm to 1:00 pm
Lunch

Afternoon Session
1:00 pm to 3:10 pm Session Moderator: Jae-Kyu Roh, MD, Seoul Korea
3:30 pm to 5:50 pm Session Moderator: Martin Brown, MD, London, UK

1:00 pm
Novel Gene(s) for Moyamoya Disease: Insight into the Pathogenesis
Keynote Speaker: Dianna Milewicz MD, PhD
Houston, TX, USA

1:40 pm
Intraoperative Infrared Brain Surface Monitoring During STA-MCA Anastomosis in Moyamoya Disease: Implication for Detection and Management of Postoperative Hyperperfusion
Atsuhiro Nakagawa MD, PhD
Sendai, Japan

2:10 pm
Unilateral Intracranial Childhood Arteriopathies
Kees Braun MD
Utrecht, Netherlands

2:40 pm
Recent trends in adult moyamoya disease: Results from a nationwide survey
Mario Zuccarello MD
Cincinnati, OH, USA

3:10 pm to 3:30 pm
Break

3:30 pm
Asymptomatic Patients with Moyamoya: Should they be treated with Surgical Revascularization
Catharina Klijn MD
Utrecht, Netherlands

4:00 pm
Clinical and Quantitative Angiographic Outcomes from Indirect Revascularization Surgery for Moyamoya Disease
Nestor Gonzalez MD
Los Angeles, CA, USA

4:30 pm
Clinical Features, Surgical Treatment, and Long-Term Outcome of Adult Moyamoya Patients
Robert Starke MD, MSC
Charlottesville, VA, USA

5:00 pm
Direct STA-MCA and STA-ACA bypass in European moyamoya angiopathy
Nadia Khan, MD
Zurich, Switzerland

5:30 pm
Closing remarks
Gary K Steinberg MD, PhD
Stanford, CA, USA